Latest news with #SNSInsider
Yahoo
6 days ago
- Business
- Yahoo
Hepatitis Testing Market Size to Reach USD 5.75 Billion by 2032 Driven by Rising Prevalence, Early Detection Demand, and Technological Advancements
U.S. Hepatitis Testing Market to Hit USD 1.94 Billion by 2032, Robust Infrastructure and Growing Demand for Early Detection Tools Fuels Growth. Austin, July 18, 2025 (GLOBE NEWSWIRE) -- Hepatitis Testing Market Size & Growth Analysis: According to SNS Insider, the global Hepatitis Testing Market was valued at USD 3.53 billion in 2023 and is projected to reach USD 5.75 billion by 2032, growing at a CAGR of 5.62% during the forecast period 2024-2032. The global hepatitis testing market is growing significantly due to the increasing incidence of hepatitis B and C infections, growing awareness around early diagnosis, and government-driven screening programs. Further, technological improvements in serological and molecular testing have enhanced test sensitivity and turnaround times, contributing to market Your Free Sample Copy of the Hepatitis Testing Market Report Today: The U.S. accounted for a substantial portion of the global market, valued at USD 1.22 billion in 2023, and is projected to reach USD 1.94 billion by 2032. This dominance is attributed to the presence of major diagnostic players, high healthcare spending, and a robust testing infrastructure across hospitals and diagnostic laboratories. Market Overview The hepatitis testing market is growing owing to the increase in demand for accurate diagnostic products, especially with the increase in the number of global hepatitis infections. Public health organizations such as the WHO and CDC are promoting mass screening and early diagnosis policies, extending the scope and frequency of hepatitis testing across the globe. Multitarget detection has changed the testing landscape with respect to hepatitis viruses in recent years, especially due to advancements in immunoassay and PCR-based diagnostics that now allow simultaneous testing. Furthermore, growing trend towards integrated healthcare systems and government initiatives for reimbursement policies will encourage the adoption of diagnosis testing kits. Developed regions such as North America and Europe with well-established laboratory networks and insurance policies conducive to mass screening. At the same time, low and middle-income countries are fast catching up because of increased awareness and international healthcare partnerships. The rising interest in point-of-care testing and home-use testing products will also drive long-term market growth in the next ten years. Major Players Analysis Listed in this Report are: Abbott Laboratories (Architect Anti-HCV, Alinity HCV) Analytik Jena (AdiSelect HCV, AdiSelect HCV Real-Time PCR Kit) Autobio Diagnostics (HCV Antibody Test Kit, HEV Antibody Test Kit Bio-Mérieux (VIDAS Anti-HCV, VIDAS HEV) Danaher Corporation (Cepheid Xpert HCV, LumiraDx HCV Test) DiaSorin (LIAISON HCV, LIAISON HCV) Grifols SA (Procleix HCV Assay, Procleix HEV Assay) Hologic Inc. (Aptima HCV Assay, Aptima HEV Assay) MedMira Inc. (Reveal HCV Test, Reveal HEV Test) Ortho-Clinical Diagnostics (Vitros Anti-HCV Test, Vitros HEV Test) Qualpro Diagnostics (HCV Rapid Test, HEV Rapid Test) Roche Molecular Diagnostics (Cobas HCV Test, Cobas HEV Test Siemens Healthcare (ADVIA Centaur HCV, Dimension Vista HEV) Sysmex Corporation (Sysmex HCV Test, Sysmex HCV Test) Thermo Fisher Scientific (TaqMan HCV Test, HCV Viral Load Test) PerkinElmer (HCV Viral Load Test, HEV Serology Test) Qiagen (QIAstat-Dx Respiratory Panel, QIAamp Viral RNA Mini Kit) Becton, Dickinson and Company (BD) (BD MAX HCV Test, BD Veritor System forHCV) Myriad Genetics (Myriad RBM HCV Antibody Test, F. Hoffmann-La Roche LtD Hepatitis Testing Market Report Scope Report Attributes Details Market Size in 2023 US$ 3.53 billion Market Size by 2032 US$ 5.75 billion CAGR (2024–2032) 5.62% U.S. Market 2023 USD 1.22 billion U.S. Forecast by 2032 USD 1.94 billion Base Year 2023 Forecast Period 2024–2032 Key Regional Coverage North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) Segment Analysis By Test: In 2023, the highest proportion of the diagnostic methods preferred for hepatitis detection was blood tests, which is primarily due to their non-invasive nature, high accuracy, and suitability for the detection of various hepatitis virus types (HBV, HCV, HAV, HEV). These tests are commonly used in hospitals and labs to screen for disease on a large scale. Imaging Studies Imaging procedures (primarily not used for diagnostic purposes) include ultrasound sonography and elastography, which are developing at a remarkable pace, especially in the context of the management of chronic viral hepatitis in the assessment of liver fibrosis. By Technology: ELISA technology dominated due to its dependable nature, cost-effectiveness, and production of high-throughput tests. It is a widely used method for the detection of hepatitis antigens and antibodies in all healthcare facilities. The PCR is more and more widely used as it is unequaled in sensitivity and accuracy, competing with viral RNA/DNA potentially at its early stage for a precise diagnosis and follow-up of patients. By End User: The Hospitals and Diagnostic Laboratories market is the largest revenue-generating testing location on account of a wider reach (hence greater accessibility), presence of high-end laboratory equipment for testing, and alignment with insurance-based payment models. The Home care segment is augmenting in the domestic hepatitis devices market as the preference for self-testing, home diagnostic kits, and remote care health monitoring grows among chronic hepatitis patients and the at-risk population. By Product: Reagents and Kits (60% contribution in 2023): Reagents and kits will continue to be at the centre-stage of hepatitis testing protocols, given their high utilization, the need for re-testing, and product advancements that increase test accuracy and reliability. Instruments: Increasing technology for automating tests, particularly in PCR and immunoassay systems, is a key growth driver for instruments in centralized and decentralized diagnostic locations. For a Personalized Briefing with Our Industry Analysts, Connect Now: Hepatitis Testing Market Segmentation By Test Blood tests Imaging tests Liver Biopsy By Technology Enzyme-linked immunosorbent assay (ELISA) Rapid Diagnostic Test Polymerase Chain Reaction (PCR) Isothermal Nucleic Acid Amplification Technology (INAAT) Others By End Use Hospitals & Diagnostic Labs Blood Banks Others By Product Instruments Reagents & Kits Regional Analysis In 2023, North America accounted for the largest share of the hepatitis testing market, with 43% of the global share, mainly due to high awareness levels, organized screening programs, and investments in the development of advanced diagnostic technologies. The APAC market is projected to witness the highest growth rate during the forecast period, due to the rising prevalence of hepatitis B and C, developed healthcare infrastructure, and favorable government policies in countries such as China, India, and Southeast Asia. Recent Developments In November 2023, F. Hoffmann-La Roche Ltd Two automated serology tests for hepatitis E diagnosis (Elecsys Anti-HEV IgM, IgG). These tests are among those on WHO's Essential Diagnostics List. In April 2024, BioMérieux unveiled a fully automated hepatitis B and C multiplex assay on its VIDAS platform, which is expected to offer a faster turnaround time in clinical labs. In March 2024, Abbott Laboratories designed an enhanced version of its RealTime HCV test on the m2000 platform to further increase sensitivity for low viral load the Full Hepatitis Testing Market Report (Single-User License) Now: Table of Contents – Major Key Points 1. Introduction 2. Executive Summary 3. Research Methodology 4. Market Dynamics Impact Analysis 5. Statistical Insights and Trends Reporting 6. Competitive Landscape 7. Hepatitis Testing Market by Type 8. Hepatitis Testing Market by Technology 9. Hepatitis Testing Market by End Use 10. Hepatitis Testing Market by Product 11. Regional Analysis 12. Company Profiles 13. Use Cases and Best Practices 14. Conclusion About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: info@
Yahoo
7 days ago
- Business
- Yahoo
Composable Infrastructure Market to Reach USD 165.80 Billion by 2032 Amid Surging Demand for Agile, Scalable IT Architectures
U.S. Composable Infrastructure Market Set to Exceed USD 23.90 Billion by 2032, Driven by Cloud-Native Adoption and Enterprise Digital Transformation. Austin, July 17, 2025 (GLOBE NEWSWIRE) -- Composable Infrastructure Market Size Analysis: According to SNS Insider, The Composable Infrastructure Market, valued at USD 7.62 billion in 2024, is projected to surge to USD 165.80 billion by 2032, expanding at a remarkable CAGR of 47% from 2025 to 2032. This accelerated expansion is fueled by the increasing need for flexible, scalable, and cost-effective IT architectures facilitating the allocation of workloads over the compute, storage, and network resources on the fly. Rapid hybrid and multi-cloud adoption, combined with enterprise-driven focus on data center efficiency and automation, are only adding fuel to the fire of further market growth. Also contributing to the interest in composable architectures in various industries is the move to DevOps and infrastructure as code (IaC) Your Free Sample Copy of the Composable Infrastructure Market Report Today: The U.S. Composable Infrastructure Market was valued at USD 1.30 billion in 2024 and is expected to reach USD 23.90 billion by 2032, growing at a CAGR of 43.92%. Growth is fueled by increasing demand for IT agility, rising adoption of cloud-native technologies, and the need for flexible infrastructure to support evolving enterprise workloads and digital transformation. Major Players Analysis Listed in this Report are: Hewlett-Packard Enterprise Development LP Cisco Systems Inc. Dell Technologies Inc. Huawei Technologies Co. Ltd. Inspur Group Co. Ltd. Lenovo Group Limited NEC Corporation NTT Ltd. SAP SE TidalScale Inc. and others Composable Infrastructure Market Report Scope Report Attributes Details Market Size in 2024 US$ 7.62 billion Market Size by 2032 US$ 165.80 billion CAGR CAGR of 47% From 2025 to 2032 Base Year 2024 Forecast Period 2025-2032 Historical Data 2021-2023 Regional Analysis North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) Key Growth Drivers Growing Demand for Agile and Scalable IT Infrastructure Drives Market Expansion Segment Insights By Component, Hardware Segment Dominated the Composable Infrastructure Market in 2024 with 76.49% Revenue Share In 2024, the hardware segment led the composable infrastructure market, accounting for 76.49% of total revenue. This dominance stems from rising demand for high-performance, modular servers, storage, and networking components. Key players like HPE, Dell Technologies, and Cisco are innovating advanced hardware solutions to meet enterprise needs for flexible, software-defined infrastructure architectures. By Organization Size, Large Enterprises Led the Composable Infrastructure Market in 2024 with 61.99% Revenue Share Owing to High Data Volumes and Dynamic Workload Demands In 2024, large enterprises held a commanding 61.99% share of the composable infrastructure market. These organizations operate vast data centers and manage critical applications with massive data loads. Composable infrastructure enables them to dynamically allocate compute, storage, and networking resources, enhancing operational efficiency and scalability to meet evolving workload demands across complex enterprise environments. By End Use, IT and Telecommunication Industry Dominated the Composable Infrastructure Market in 2024 with 30.58% Revenue Share In 2024, the IT and telecommunication industry led the composable infrastructure market with a 30.58% revenue share. This dominance stems from growing adoption of edge computing and network function virtualization (NFV). Telecom providers are embracing decentralized architectures to reduce latency, support edge devices, and enhance service delivery, driving demand for flexible, software-defined infrastructure solutions across the sector. For a Personalized Briefing with Our Industry Analysts, Connect Now: Composable Infrastructure Market Segmentation By Component Software Hardware By Organization Size Large Enterprises Small and Medium-sized Enterprises (SMEs) By End Use BFSI IT & Telecommunication Retail & Consumer Goods Healthcare Manufacturing Others North America Accounted for 35.70% Share in the Composable Infrastructure Market, Asia Pacific Emerged as the Fastest-Growing Region In 2024, North America held a significant 35.70% share of the composable infrastructure market. This dominance is attributed to early technology adoption, a well-established IT landscape, and the presence of major vendors. Strong demand from sectors such as BFSI, telecom, and healthcare continues to propel regional growth, fueled by the need for scalable and agile infrastructure solutions. Asia Pacific is witnessing the fastest growth in the composable infrastructure market with a 47.43% CAGR from 2025 to 2032. This has been primarily fueled by the rapid digital transformation, investments in cloud & edge computing, and rising demand from both large enterprise as well as SMEs in the region. With the belief that the IT infrastructure benefits the economic growth and innovation, governments, together with the businesses are modernising their IT infrastructure. Buy the Full Composable Infrastructure Market Report (Single-User License) Now: Table of Contents – Major Key Points 1. Introduction 2. Executive Summary 3. Research Methodology 4. Market Dynamics Impact Analysis 5. Statistical Insights and Trends Reporting 5.1 System and Software Deployment Metrics 5.2 Security and Data Protection Metrics 5.3 Security Impact 5.4 Edge Computing Adoption Impact 6. Competitive Landscape 7. Composable Infrastructure Market by Component 8. Composable Infrastructure Market by Organization Size 9. Composable Infrastructure Market by End Use 10. Regional Analysis 11. Company Profiles 12. Use Cases and Best Practices 13. Conclusion About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: info@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
15-07-2025
- Business
- Yahoo
Non-Invasive Fat Reduction Market to Hit USD 6.21 Billion by 2032, Driven by Social Media Influence and Growing Aesthetic Consciousness, Reports SNS Insider
U.S. Non-Invasive Fat Reduction Market Expected to Surpass USD 2.07 Billion by 2032 at a CAGR of 16.45%, Fueled by Disposable Income and Demand for Safe, Non-Surgical Cosmetic Solutions. Austin, July 15, 2025 (GLOBE NEWSWIRE) -- Non-Invasive Fat Reduction Market Size & Growth Analysis: According to SNS Insider, the global Non-Invasive Fat Reduction Market is projected to grow from USD 1.56 billion in 2023 to USD 6.21 billion by 2032, registering a CAGR of 16.67% during the forecast period of 2024-2032. The global non-invasive fat reduction market is growing rapidly due to the prevalence of physical appearance and body image consciousness is on the rise globally, fueled by lifestyle changes and urbanisation, and due to the impact of the media. Men and women alike are searching for non-surgical methods of cosmetic procedures that will boost self-esteem. A cultural trend becoming more prevalent is the desire to appear fit and young. This increased desire to look fit and young is driving demand for non-invasive fat reduction a Sample Report of Non-Invasive Fat Reduction Market@ The U.S. non-invasive fat reduction market was estimated at USD 526.01 million in 2023 and is expected to reach USD 2071.56 million by 2032, at a CAGR of 16.45% during the forecast period of 2024-2032 The U.S is leading the non-invasive fat reduction market in North America due to the large number of people who have disposable income, which they can use to pay for elective and cosmetic treatments that health insurance does not cover. This disposable income motive stimulates people to opt for the non-invasive fat-reducing sessions for cosmetic reasons. Major Players Analysis Listed in this Report are: Allergan (CoolSculpting, CoolTone) Cynosure (SculpSure, TempSure Firm) Alma Lasers (Accent Prime, Accent Elite) Cutera, Inc. (truSculpt iD, truSculpt Flex) BTL Aesthetics (EMSCULPT, EMTONE) Lumenis Ltd. (NuEra Tight, UltraShape Power) Venus Concept Inc. (Venus Bliss, Venus Legacy) InMode Ltd. (BodyTite, Morpheus8 Body) Zeltiq Aesthetics (CoolAdvantage, CoolMini) Solta Medical (Thermage FLX, Liposonix) Fotona (SP Dynamis, StarWalker) Sciton, Inc. (JOULE X, ProLipo PLUS) Medtronic (VaserShape, VaserLipo) Zimmer Biomet (Z Wave Pro, Z Cryo) Syneron Candela (UltraShape, VelaShape) REVOLVE Aesthetics (AirSculpt Laser Lipo, AirSculpt+) Hitech Lasers (LipoZero G2, CaviPlus) ThermiGen LLC (ThermiSmooth Body, ThermiTight) Advalight (ADVATx, UltraContour) Evonik Industries (Ultherapy, CelluContour) Non-Invasive Fat Reduction Market Report Scope Report Attributes Details Market Size in 2023 US$ 1.56 billion Market Size by 2032 US$ 6.21 billion CAGR CAGR of 16.67% From 2024 to 2032 Base Year 2023 Forecast Period 2024-2032 Historical Data 2020-2022 Regional Analysis North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) Segment Analysis Cryolipolysis Segment is Anticipated to Hold the Largest Share of the Non-Invasive Fat Reduction Market, By Technology In 2023, the cryolipolysis segment held the largest market share with 35.45%, driven by its safety profile, quick recovery for patients, and great fat reduction outcomes. FDA approvals, extensive clinical utilization, and demonstrable patient interest in non-invasive, targeted body contouring also position the treatment well above alternative treatments, including ultrasound or laser technologies. Based on End-Use, the Hospital Segment Accounted for the Largest Share of the Non-Invasive Fat Reduction Market The hospital segment dominated the non-invasive fat reduction market in 2023 with a 55.41% market share, owing to its advanced infrastructure, availability of certified professionals, and access to FDA-approved technologies. Patients prefer hospitals for safety, comprehensive care, and trusted clinical expertise, especially for procedures requiring precise monitoring and post-treatment support, driving higher procedure volumes in this setting. By End-Use, the Hospital Segment is Emerging as the Fastest Growing Segment of the Non-Invasive Fat Reduction Market In 2023, the hospital segment held the largest share of the non-invasive fat reduction market, owing to growing confidence among patients for supervised procedures and increased penetration of aesthetic services within hospitals. Stronger safety requirements, use of sophisticated devices, and expansion of collaboration with cosmetic device manufacturers are speeding up the cosmetic practice of shaping with body fat liquefaction. For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@ Non-Invasive Fat Reduction Market Segmentation By Technology Cryolopolysis Lower-level Laser Ultra-sound Others By End-Use Hospitals Stand-alone Practices Multispecialty Clinics Others Non-Invasive Fat Reduction Market is Expected to Register Fastest Growth in Asia-Pacific, North America Dominates The non-invasive fat reduction market in North America accounted for the largest share of 39.46% in 2023, driven by its high rates of obesity, robust consumer interest in cosmetic treatments, and easy access to advanced technology. Favourable regulatory approvals and well-established market players in the region favour the dominance of the region in the use of non-invasive body contouring procedures. The Asia-Pacific region is estimated to grow at the highest CAGR during the forecast period, owing to an increasing middle-class populace, increasing awareness towards aesthetic procedures, and increasing healthcare infrastructure. Declining treatment costs, a higher number of trained professionals, and aggressive marketing by global and regional players are the growth drivers. Moreover, the rise of medical tourism and changing cultural attitudes toward aesthetic enhancement contribute to market growth. Buy a Single-User PDF of Non-Invasive Fat Reduction Market Analysis & Outlook Report 2024-2032@ Table of Contents – Major Key Points 1. Introduction 2. Executive Summary 3. Research Methodology 4. Market Dynamics Impact Analysis 5. Statistical Insights and Trends Reporting 5.1 Incidence and Prevalence of Obesity and Overweight Population (2023) 5.2 Technology Trends and Patient Preferences (2023), by Region 5.3 Healthcare Spending on Aesthetic Procedures, by Region (Government, Commercial, Private, Out-of-Pocket), 2023 5.4 Technological Advancements and Adoption Trends (2023) 6. Competitive Landscape 7. Non-Invasive Fat Reduction Market by Technology 8. Non-Invasive Fat Reduction Market by End-Use 9. Regional Analysis 10. Company Profiles 11. Use Cases and Best Practices 12. Conclusion Related Reports Body Contouring Devices Market Report Medical Aesthetics Market Insights Cosmetic Surgery Market Trends About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: info@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14-07-2025
- Business
- Yahoo
Compounding Pharmacies Market to Hit USD 19.9 Billion by 2032 Due to Rising Demand for Personalized Medications and Specialty Drug Shortages
U.S. Market Set to Reach USD 4.84 Billion by 2032, Fueled by the Surge in Tailored Prescriptions and Favorable Regulatory Support. Austin, July 14, 2025 (GLOBE NEWSWIRE) -- Compounding Pharmacies Market Size & Growth Analysis: According to SNS Insider, the global Compounding Pharmacies Market is witnessing a significant transformation, projected to grow from USD 12.6 billion in 2023 to USD 19.9 billion by 2032, expanding at a CAGR of 5.2%. In the United States, the market is advancing from USD 2.74 billion in 2024 to an anticipated USD 4.84 billion by 2032, driven by the accelerating demand for personalized medicine, evolving healthcare preferences, and supportive regulatory a Sample Report of Compounding Pharmacies Market@ Compounding pharmacies have become an essential bridge between standard pharmaceutical care and customized patient needs. As healthcare systems globally pivot toward precision medicine, the ability to tailor drugs—ranging from dosage adjustments to allergen-free and unique delivery formulations—is no longer a niche requirement but a central component of modern care. The Personalized Medicine Boom As chronic illnesses proliferate and patient populations become more diverse in their healthcare needs, standardized medications are often inadequate or unsuitable. Compounding pharmacies offer solutions for patients with drug allergies, pediatric needs, geriatric sensitivities, or non-traditional dosage requirements. This patient-first model is reshaping how physicians prescribe medications, especially in fields like pain management, hormone replacement therapy (HRT), veterinary care, and oncology. In particular, the U.S. market is showing robust momentum due to the widespread adoption of personalized prescriptions, growth in aging demographics, and a favorable outlook from oversight bodies such as the FDA and Pharmacy Compounding Accreditation Board (PCAB). Recent regulatory clarity has supported the expansion of both 503A and 503B outsourcing facilities, bolstering patient safety and quality assurance. Segment Analysis By Therapeutic Area: The pain management segment was the highest contributor to the therapeutic area category in 2023, and accounted for 35.1% of the total revenue share. Non-opioid alternatives and patient-specific formulations for chronic and acute pain will continue to fuel this space. Compared with patients individually, physicians prefer ways to make doses and reduce side effects. By Age Cohort: The adult category was the largest segment in 2023, with a share of 45.1%. Adults have needs for medication for which a drug must be reconstituted for allergies, lack of ability to swallow, or the need for a different dosage while this population segment is an important market demographic. By Sterility: Sterile compounded medications were the leading segment in 2023 with an overall market share of 60.52% and demand from ophthalmology and parenteral nutrition, and intrathecal therapies, etc. These drugs must have restrictive manufacturing procedures and are typically used in the hospital, surgery center, and oncology setting. For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@ Regional Analysis The Asia Pacific was the largest compounding pharmacies market, accounting for the revenue share of over 40.4% in 2023, owing to increasing population requirements, high healthcare infrastructure, and growing personalized drug demands in China, Japan and India among others. A growing number of specialty clinics and locally developed pharmacy solutions were other factors that led the region to dominance. Europe is anticipated to grow at a CAGR based on revenue of 7.5% during the course of the forecast period 2024 to 2032 on account of rising usage of compounded drugs for pediatric and geriatric care. The European compounding pharmacy industry is projected to witness growing regulatory backing and increased pharmacy networks extended throughout Germany, France and the UK in the years to come. Major Players Analysis Listed in this Report are: Walgreen Co. Fagron Albertsons Companies The London Specialist Pharmacy Ltd Galenic Laboratories Limited Aurora Compounding MEDS Pharmacy Apollo Clinical Pharmacy Formul8 Fusion Apothecary and other players. Compounding Pharmacies Market Segmentation By Therapeutic Area Hormone Replacement Therapy Pain Management Specialty Drugs Dermatology Nutritional Supplements Others By Age Cohort Pediatric Adult Geriatric By Compounding Type Pharmaceutical Ingredient Alteration (PIA) Currently Unavailable Pharmaceutical Manufacturing (CUPM) Pharmaceutical Dosage Alteration (PDA) Others By Sterility Sterile Non-sterile Recent Developments Avita Pharmacy (2024): Created a strategic alliance with a research leader to pioneer advanced personalized compounding formulations. Medisca (2023): Released patient-focused formulations for compliance and taste preferences, such as pediatric and geriatric formulations. Fagron (February 2024): launched a series of hormone therapy compounding kits designed to help make pharmacies more efficient while also decreasing dosage variability. Compounding Pharmacies Market Report Scope Report Attributes Details Market Size in 2023 US$ 12.6 billion Market Size by 2032 US$ 19.9 billion CAGR CAGR of 5.2% From 2024 to 2032 Base Year 2023 Forecast Period 2024-2032 Historical Data 2020-2022 Regional Analysis North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) Buy a Single-User PDF of Compounding Pharmacies Market Analysis & Outlook Report 2024-2032@ Table of Contents – Major Key Points 1. Introduction 2. Executive Summary 3. Research Methodology 4. Market Dynamics Impact Analysis 5. Statistical Insights and Trends Reporting 5.1 Incidence and Prevalence (2023) 5.2 Prescription Trends, (2023), by Region 5.3 Drug Volume, by Region (2020-2032) 5.4 Healthcare Spending: Expenditure data by government, insurers, and out-of-pocket by patients. 6. Competitive Landscape 7. Compounding Pharmacies Market by Therapeutic Area 8. Compounding Pharmacies Market by Age Cohort 9. Compounding Pharmacies Market by Compounding Type 10. Compounding Pharmacies Market by Sterility 11. Regional Analysis 12. Company Profiles 13. Use Cases and Best Practices 14. Conclusion Related Reports Hormone Replacement Therapy Market Report 2024–2032 Personalized Medicine Market Size & Growth Forecast Pain Management Market Analysis About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: info@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
11-07-2025
- Business
- Yahoo
Cryptojacking Solution Market to Reach USD 74.1 Billion by 2032, Driven by AI-Powered Threat Detection and Expanding Attack Surfaces
According to Research by SNS Insider, U.S. Cryptojacking Solution Market Set to Hit USD 1.32 Billion by 2032 Amid Rising Cyber Threats and Surge in Cloud Adoption. Austin, July 11, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, The Cryptojacking Solution Market was valued at USD 21.4 billion in 2024 and is projected to reach USD 74.1 billion by 2032, expanding at a CAGR of 16.79% from 2025 to 2032. With the increase in the number of cryptojacking attacks and rising awareness regarding cybersecurity threats, the market for cryptojacking solution is likely to grow exponentially. With greater reliance on cloud services, IoT devices, and distributed workplaces, enterprises have more attack surfaces to cover, and need advanced detection and protection capabilities. Moreover, the rise in need to protect organizational network and endpoints against the background resource exploitation drives the market growth excellence regulatory frameworks are strict, which also anticipates the market growth over the forecast a Sample Report of Cryptojacking Solution Market@ The U.S. Cryptojacking Solution Market, valued at USD 480 million in 2024, is projected to reach USD 1.32 billion by 2032, growing at a CAGR of 13.2%. Increasing cloud adoption, rising cyberattacks targeting computing resources, and strict data privacy regulations are driving demand. Organizations seek advanced cryptojacking detection tools to protect digital assets, ensure compliance, and maintain performance across expanding IT infrastructures and remote work environments. Major Players Analysis Listed in this Report are: Cisco Palo Alto Networks McAfee Symantec CrowdStrike Check Point Software Trend Micro Sophos Kaspersky FireEye others Cryptojacking Solution Market Report Scope Report Attributes Details Market Size in 2024 US$ 21.4 billion Market Size by 2032 US$ 74.1 billion CAGR CAGR of 16.79% From 2025 to 2032 Base Year 2024 Forecast Period 2025-2032 Historical Data 2021-2023 Regional Analysis North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) By Component, Solution Segment Led the Cryptojacking Solution Market, Services Segment to Record Fastest CAGR In 2024, the solution segment held a dominant 68% revenue share, driven by increasing adoption of AI and machine learning methods to monitor the network and provide alerts for cryptojacking. To face cyberattacks that are becoming more and more sophisticated, organizations now turn to automated, scalable security software. Cloud migration and digitalization continue to drive the adoption of proactive cryptojacking prevention solutions. The services segment is anticipated to grow at the fastest CAGR from 2025 to 2032, owing to the increasing dependencies on managed and professional services, fueled by the vacuum of experts in cybersecurity. Companies want assistance with the implementation, management and updating of these cryptojacking protections. The cyber security embedded service-based offerings are unrivaled in addressing increasingly elaborate and persistent cyber threats with continuous threat monitoring, incident response, and evolving threat intelligence. By Deployment, Cloud Segment Dominated the Cryptojacking Solution Market in 2024 with 71% Share Due to Scalability, Flexibility, and Cost Efficiency In 2024, the cloud segment held 71% of the cryptojacking solution market, due to the increasing adoption of cloud-based security tools. These solutions provide scalability, flexibility, and rapid deployment agility with minimal infrastructure expense. With growing cloud adoption across industries, the need for seamless, cloud-native cryptojacking protection is increasing, complementing broader cybersecurity postures in dynamic, distributed IT ecosystems. By Industry, BFSI Segment Led the Cryptojacking Solution Market, Healthcare Segment to Witness Fastest CAGR In 2024, the BFSI segment accounted for the largest revenue share in the cryptojacking solution market. This dominance is driven by the high volume of financial transactions and the critical sensitivity of financial data. As cryptojacking attacks pose severe risks of monetary loss and reputational harm, financial institutions are investing heavily in robust cybersecurity frameworks to safeguard digital assets and customer trust. The healthcare segment is expected to grow at the fastest CAGR during 2025–2032, propelled by widespread digitalization of patient records and rising use of connected medical devices. These factors provide openings that sensor cryptojackers can take advantage of, which can lead to serious consequences, such as hindering these critical services and risking patient data. Highlighting the dangers, the sector is rapidly embracing advanced solutions for cryptojacking to maintain operations and increase safety of sensitive health information. For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@ Cryptojacking Solution Market Segmentation By Component Solution Services Professional Services Consulting Training And Education Support And Maintenance Managed Services By Deployment Cloud-Based On-Premises. By Industry BFSI Retail Government And Public Sector Manufacturing Healthcare Education Energy And Utilities Others. North America Led the Cryptojacking Solution Market, Asia Pacific to Witness Fastest CAGR In 2024, North America held a 38% revenue share in the cryptojacking solution market, due to advanced digital infrastructure, stricter regulations on cybersecurity, and high technology adoption. High implementation of leading cybersecurity vendors, demand from BFSI and healthcare sectors, and heavy emphasis on data protection helped the U.S. reach among the core suppliers in the global market. Asia Pacific is expected to register the fastest CAGR during the forecast period, fueled by increasing digitalization, cloud adoption, and a surge in cyber threats. Countries like China, India, Japan, and South Korea are enhancing cybersecurity infrastructure to protect growing investments. Initiatives in smart cities and digital governance are also boosting the demand for advanced cryptojacking protection across the region. Buy a Single-User PDF of Cryptojacking Solution Market Analysis & Outlook Report 2024-2032@ Table of Contents – Major Key Points 1. Introduction 2. Executive Summary 3. Research Methodology 4. Market Dynamics Impact Analysis 5. Statistical Insights and Trends Reporting 6. Competitive Landscape 7. Cryptojacking Solution Market by Component 8. Cryptojacking Solution Market by Deployment 9. Cryptojacking Solution Market by Industry 10. Regional Analysis 11. Company Profiles 12. Use Cases and Best Practices 13. Conclusion About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: info@
